Treatments for infantile Hemangioma: A systematic review and network meta-analysis

Autor: Qiang Fei, Yu Lin, Xian Chen
Rok vydání: 2020
Předmět:
Cochrane Library
01 natural sciences
law.invention
0302 clinical medicine
Randomized controlled trial
law
Prednisone
Medicine
030212 general & internal medicine
Network meta-analysis
SUCRA
surface under the cumulative ranking curve

PRO
propranolol

PED
prednisone

lcsh:R5-920
IH
infantile hemangioma

PDL
pulsed dye laser

OR
odds ratios

General Medicine
IMQ
imiquimod

L
a longer treatment duration

Meta-analysis
S
a shorter treatment duration

ATL
atenolol

Nd
Nd:YAG laser

Hemangioma
lcsh:Medicine (General)
CAP
captopril

Research Paper
medicine.drug
LPDL
PDL at a long pulse duration

medicine.medical_specialty
Therapeutics
Propranolol
Laser
PDL and Nd:YAG laser

03 medical and health sciences
Internal medicine
0101 mathematics
Adverse effect
H
a higher dose

TA
triamcinolone

business.industry
010102 general mathematics
Atenolol
medicine.disease
β
topical β-blockers treatment

CI
confidence intervals

RCT
randomized clinical trials

NMA
network meta-analysis

business
Zdroj: EClinicalMedicine, Vol 26, Iss, Pp 100506-(2020)
EClinicalMedicine
ISSN: 2589-5370
DOI: 10.1016/j.eclinm.2020.100506
Popis: Background Infantile hemangioma (IH) is common in children, which may bring about cosmetically disfiguring, functional impairment, and exhibiting complications. There had been various therapies and we aimed to assess the efficacy and adverse effects of different therapies through network meta-analysis. Methods We searched PubMed, Embase, Cochrane Library and Web of Science (from database inception to April 11, 2020) for studies assessing the efficacy, success rate and adverse effects. Direct pairwise comparison and a network meta-analysis under random effects were performed. We also assessed the ranking probability. Findings A total of 30 randomized clinical trials with more than 20 different therapeutic regimens were identified. Treatment combined propranolol orally with laser could improve the curative effect than monotherapy. Laser with topical β blockers showed more efficiency than others whether in children under 6 months or not. The long-pulsed dye laser might be the best laser therapy. A higher dose and a longer treatment duration of propranolol orally achieved a higher success rate and increased side effects. Plus pulse dye laser with propranolol had the lowest incidence of adverse reactions, such as ulcer, color sink and color reduction. Interpretation A combination of β blockers and laser might be the first-line treatment of IHs and a longer pulsed dye laser is preferred. Funding No funding was received.
Databáze: OpenAIRE